Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Cancer Gene Ther ; 22(9): 454-62, 2015 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-26337747

RESUMO

We have investigated if immunotherapy against human papilloma virus (HPV) using a viral gene delivery platform to immunize against HPV 16 genes E6 and E7 (Ad5 [E1-, E2b-]-E6/E7) combined with programmed death-ligand 1 (PD-1) blockade could increase therapeutic effect as compared to the vaccine alone. Ad5 [E1-, E2b-]-E6/E7 as a single agent induced HPV-E6/E7 cell-mediated immunity. Immunotherapy using Ad5 [E1-, E2b-]-E6/E7 resulted in clearance of small tumors and an overall survival benefit in mice with larger established tumors. When immunotherapy was combined with immune checkpoint blockade, an increased level of anti-tumor activity against large tumors was observed. Analysis of the tumor microenvironment in Ad5 [E1-, E2b-]-E6/E7 treated mice revealed elevated CD8(+) tumor infiltrating lymphocytes (TILs); however, we observed induction of suppressive mechanisms such as programmed death-ligand 1 (PD-L1) expression on tumor cells and an increase in PD-1(+) TILs. When Ad5 [E1-, E2b-]-E6/E7 immunotherapy was combined with anti-PD-1 antibody, we observed CD8(+) TILs at the same level but a reduction in tumor PD-L1 expression on tumor cells and reduced PD-1(+) TILs providing a mechanism by which combination therapy favors a tumor clearance state and a rationale for pairing antigen-specific vaccines with checkpoint inhibitors in future clinical trials.


Assuntos
Antígeno B7-H1/biossíntese , Vacinas Anticâncer/uso terapêutico , Imunoterapia , Proteínas Oncogênicas Virais/imunologia , Papillomaviridae/imunologia , Proteínas E7 de Papillomavirus/imunologia , Proteínas Repressoras/imunologia , Infecções Tumorais por Vírus/terapia , Neoplasias do Colo do Útero/terapia , Animais , Apoptose/genética , Antígeno B7-H1/antagonistas & inibidores , Antígeno B7-H1/genética , Linhagem Celular Tumoral , Terapia Combinada , Vírus Defeituosos/genética , Vírus Defeituosos/imunologia , Feminino , Regulação da Expressão Gênica , Humanos , Imunoglobulina G/imunologia , Contagem de Linfócitos , Linfócitos do Interstício Tumoral/imunologia , Camundongos , Camundongos Endogâmicos C57BL , Proteínas Oncogênicas Virais/genética , Papillomaviridae/genética , Proteínas E7 de Papillomavirus/genética , Ratos , Proteínas Repressoras/genética , Linfócitos T Citotóxicos/imunologia , Microambiente Tumoral , Infecções Tumorais por Vírus/patologia , Neoplasias do Colo do Útero/patologia , Neoplasias do Colo do Útero/virologia , Ensaios Antitumorais Modelo de Xenoenxerto
2.
Biochemistry ; 40(14): 4398-406, 2001 Apr 10.
Artigo em Inglês | MEDLINE | ID: mdl-11284696

RESUMO

Dual-specificity phosphatase MKP3 down-regulates mitogenic signaling through dephosphorylation of extracellular regulated kinase (ERK). Unlike a simple substrate-enzyme interaction, the noncatalytic, amino-terminal domain of MKP3 can bind efficiently to ERK, leading to activation of the phosphatase catalytic domain by as much as 100-fold toward exogenous substrates. It has been suggested that ERK activates MKP3 through the stabilization of the active phosphatase conformation, enabling general acid catalysis. Here, we investigated whether Asp-262 of MKP3 is the bona fide general acid and evaluated its contribution to the catalytic steps activated by ERK. Using site-directed mutagenesis, pH rate and Brönsted analyses, kinetic isotope effects, and steady-state and rapid reaction kinetics, Asp-262 was identified as the authentic general acid catalyst, donating a proton to the leaving group oxygen during P-O bond cleavage. Kinetic isotope effects [(18)(V/K)(bridge), (18)(V/K)(nonbridge), and (15)(V/K)] were evaluated for the effect of ERK and of the D262N mutation on the transition state of the phosphoryl transfer reaction. The patterns of the three isotope effects for the reaction with native MKP3 in the presence of ERK are indicative of a reaction where the leaving group is protonated in the transition state, whereas in the D262N mutant, the leaving group departs as the anion. Even without general acid catalysis, the D262N mutant reaction is activated by ERK through increased phosphate affinity ( approximately 8-fold) and the partial stabilization of the transition state for phospho-enzyme intermediate formation ( approximately 4-fold). Based on these analyses, we estimate that dephosphorylation of phosphorylated ERK by the D262N mutant is >1000-fold lower than by native, activated MKP3. Also, the kinetic results suggest that Asp-262 functions as a general base during thiol-phosphate intermediate hydrolysis.


Assuntos
Ácido Aspártico/metabolismo , Proteínas Quinases Ativadas por Mitógeno/metabolismo , Proteínas Tirosina Fosfatases/metabolismo , Substituição de Aminoácidos/genética , Asparagina/genética , Ácido Aspártico/genética , Sítios de Ligação/genética , Catálise , Fosfatase 3 de Especificidade Dupla , Fosfatase 6 de Especificidade Dupla , Ativação Enzimática/genética , Concentração de Íons de Hidrogênio , Cinética , Mutagênese Sítio-Dirigida , Nitrogênio , Isótopos de Nitrogênio , Nitrofenóis/metabolismo , Compostos Organofosforados/metabolismo , Isótopos de Oxigênio , Fosforilação , Proteínas Tirosina Fosfatases/genética , Especificidade por Substrato/genética
3.
J Biol Chem ; 275(10): 6749-57, 2000 Mar 10.
Artigo em Inglês | MEDLINE | ID: mdl-10702230

RESUMO

The dual specificity mitogen-activated protein kinase phosphatase MKP3 has been shown to down-regulate mitogenic signaling through dephosphorylation of extracellular signal-regulated kinase (ERK). Camps et al. (Camps, M., Nichols, A., Gillieron, C., Antonsson, B., Muda, M., Chabert, C., Boschert, U., and Arkinstall, S. (1998) Science 280, 1262-1265) had demonstrated that ERK binding to the noncatalytic amino-terminal domain of MKP3 can dramatically activate the phosphatase catalytic domain. The physical basis for this activation has not been established. Here, we provide detailed biochemical evidence that ERK activates MKP3 through the stabilization of the active phosphatase conformation, inducing closure of the catalytic "general acid" loop. In the closed conformation, this loop structure can participate efficiently in general acid/base catalysis, substrate binding, and transition-state stabilization. The pH activity profiles of ERK-activated MKP3 clearly indicated the involvement of general acid catalysis, a hallmark of protein-tyrosine phosphatase catalysis. In contrast, unactivated MKP3 did not display this enzymatic group as critical for the low activity form of the enzyme. Using a combination of Brönsted analyses, pre-steady-state and steady-state kinetics, we have isolated all catalytic steps in the reaction and have quantified the specific rate enhancement. Through protonation of the leaving group and transition-state stabilization, activated MKP3 catalyzes formation of the phosphoenzyme intermediate approximately 100-fold faster than unactivated enzyme. In addition, ERK-activated MKP3 catalyzes intermediate hydrolysis 5-6-fold more efficiently and binds ligands up to 19-fold more tightly. Consistent with ERK stabilizing the active conformation of MKP3, the chemical chaperone dimethyl sulfoxide was able to mimic this activation. A general protein-tyrosine phosphatase regulatory mechanism involving the flexible general acid loop is discussed.


Assuntos
Proteína Quinase 1 Ativada por Mitógeno/farmacologia , Proteínas Quinases Ativadas por Mitógeno/farmacologia , Proteínas Tirosina Fosfatases/metabolismo , Catálise , Dimetil Sulfóxido/farmacologia , Fosfatase 6 de Especificidade Dupla , Ativação Enzimática , Concentração de Íons de Hidrogênio , Cinética , Proteína Quinase 3 Ativada por Mitógeno , Proteínas Tirosina Fosfatases/química
4.
Meat Sci ; 30(1): 1-12, 1991.
Artigo em Inglês | MEDLINE | ID: mdl-22061646

RESUMO

Tensile tests were carried out on ribbons of perimysial connective tissue dissected from slices of bovine semitendinosus muscles that had been conditioned or not conditioned and then cooked to a range of temperatures. A consistent reduction in the strength of the perimysia was seen in the conditioned samples, both in the raw meat and meat cooked to 50°C. At higher cooking temperatures (60-80°C), no effect of conditioning was seen. The content of collagen or total protein of mechanically extracted perimysia and the collagen content of the test pieces from conditioned and unconditioned muscles was not significantly different. It was concluded that conditioning decreases the breaking strength of the perimysial connective tissue in raw meat or in meat which is subsequently cooked to 50°C, but not in meat cooked to the temperatures normally employed by consumers. The tenderization observed in conditioned meat cooked to 60°C and above is, therefore, due to the weakening of muscle fibres within the fibre bundles.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...